Advertisement
UK markets close in 4 hours 16 minutes
  • FTSE 100

    8,073.16
    +49.29 (+0.61%)
     
  • FTSE 250

    19,739.42
    +140.03 (+0.71%)
     
  • AIM

    753.61
    +4.43 (+0.59%)
     
  • GBP/EUR

    1.1582
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2353
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    53,551.55
    +127.08 (+0.24%)
     
  • CMC Crypto 200

    1,424.68
    +9.92 (+0.70%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    81.55
    -0.35 (-0.43%)
     
  • GOLD FUTURES

    2,315.30
    -31.10 (-1.33%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,058.87
    +198.07 (+1.11%)
     
  • CAC 40

    8,097.73
    +57.37 (+0.71%)
     

Company News for Mar 14, 2023

  • Seagen Inc.’s SGEN shares jumped 14.5% after pharmaceutical giant Pfizer Inc. PFE decided to acquire the company for a consideration of around $43 billion.    

  • Insulet Corp.’s PODD shares climbed 8.2% following news that the company will enter the S&P 500 Index replacing from Mar 14 replacing SVB Financial Group SIVB.

  • Shares of Illumina, Inc. ILMN soared 17% after The Wall Street Journal reported that billionaire activist investor Carl Icahn preparing a proxy battle to take control of the company.

  • Shares of The PNC Financial Services Group, Inc. PNC tumbled 5.2% after the company decided not to bid for the collapsed Silicon Valley Bank.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The PNC Financial Services Group, Inc (PNC) : Free Stock Analysis Report

Pfizer Inc. (PFE) : Free Stock Analysis Report

ADVERTISEMENT

Illumina, Inc. (ILMN) : Free Stock Analysis Report

Insulet Corporation (PODD) : Free Stock Analysis Report

SVB Financial Group (SIVB) : Free Stock Analysis Report

Seagen Inc. (SGEN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research